Gene · 10499
Papers3,077
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,077
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analyzing the multi-target pharmacological mechanism of folium Artemisia argyi acting on breast cancer: a network pharmacology approach. | Ann Transl Med | 2022 | 36660662 | PubTator, text mining | PubMed |
| Mechanism of Datura metel on sinus bradycardia based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2022 | 36626429 | PubTator, text mining | PubMed |
| FAT/CD36 Participation in Human Skeletal Muscle Lipid Metabolism: A Systematic Review. | J Clin Med | 2022 | 36615118 | PubTator, text mining | PubMed |
| The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome. | Int J Mol Sci | 2022 | 36613751 | PubTator, text mining | PubMed |
| The mechanism study of Miao medicine Tongfengting decoction in the treatment of gout based on network pharmacology and molecular docking. | Medicine (Baltimore) | 2022 | 36595750 | PubTator, text mining | PubMed |
| Steroid receptor coactivators - their role in immunity. | Front Immunol | 2022 | 36582250 | PubTator, text mining | PubMed |
| Metastatic mesenchymal chondrosarcoma showing a sustained response to cabozantinib: A case report. | Front Oncol | 2022 | 36578930 | PubTator, text mining | PubMed |
| Systems Pharmacology-Based Strategy to Investigate the Mechanism of Ruangan Lidan Decoction for Treatment of Hepatocellular Carcinoma. | Comput Math Methods Med | 2022 | 36578460 | PubTator, text mining | PubMed |
| Oligoarginine-Conjugated Peptide Foldamers Inhibiting Vitamin D Receptor-Mediated Transcription. | ACS Omega | 2022 | 36570290 | PubTator, text mining | PubMed |
| Traditional Herbal Medicine: A Potential Therapeutic Approach for Adjuvant Treatment of Non-small Cell Lung Cancer in the Future. | Integr Cancer Ther | 2022 | 36567455 | PubTator, text mining | PubMed |
| Exploring the Effective Components and Mechanism of Action of Japanese Ardisia in the Treatment of Autoimmune Hepatitis Based on Network Pharmacology and Experimental Verification. | Pharmaceuticals (Basel) | 2022 | 36558908 | PubTator, text mining | PubMed |
Investigation of the Antibacterial, Anti-Biofilm, and Antioxidative Effect of Piper betle Leaf Extract against Bacillus gaemokensis MW067143 Isolated from Dental Caries, an In Vitro-In Silico Approach. | Microorganisms | 2022 | 36557738 | PubTator, text mining | PubMed |
| Next-Generation Sequencing of a Large Gene Panel for Outcome Prediction of Bariatric Surgery in Patients with Severe Obesity. | J Clin Med | 2022 | 36556146 | PubTator, text mining | PubMed |
| Impact of Adenomyosis on Infertile Patients-Therapy Options and Reproductive Outcomes. | Biomedicines | 2022 | 36552001 | PubTator, text mining | PubMed |
| Genetic Alterations and Deregulation of Hippo Pathway as a Pathogenetic Mechanism in Bone and Soft Tissue Sarcoma. | Cancers (Basel) | 2022 | 36551696 | PubTator, text mining | PubMed |
| Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma. | Cancers (Basel) | 2022 | 36551694 | PubTator, text mining | PubMed |
| Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer. | Cancers (Basel) | 2022 | 36551580 | PubTator, text mining | PubMed |
| Androgen Receptor Signaling Inhibition in Advanced Castration Resistance Prostate Cancer: What Is Expected for the Near Future? | Cancers (Basel) | 2022 | 36551557 | PubTator, text mining | PubMed |
| Systematic comparison of differential expression networks in MTB mono-, HIV mono- and MTB/HIV co-infections for drug repurposing. | PLoS Comput Biol | 2022 | 36534703 | PubTator, text mining | PubMed |
| Anaplastic Rhabdomyosarcoma of Upper Lip in a 3-Year-Old Girl. | J Indian Assoc Pediatr Surg | 2022 | 36530822 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10499/papers?page=17